[
    [
        {
            "time": "2021-ESMO",
            "original_text": "掘金创新药 | 2021ESMO年会盘点：君实生物PD-1治疗晚期食管癌生存期突破17个月 恒瑞医药新药初显抗癌潜力",
            "features": {
                "keywords": [
                    "君实生物",
                    "PD-1",
                    "恒瑞医药",
                    "ESMO",
                    "晚期食管癌",
                    "抗癌潜力"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "掘金创新药 | 2021ESMO年会盘点：君实生物PD-1治疗晚期食管癌生存期突破17个月 恒瑞医药新药初显抗癌潜力",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "拉闸限电后",
            "original_text": "拉闸限电之后，药企得注意这件事",
            "features": {
                "keywords": [
                    "拉闸限电",
                    "药企"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药行业"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "拉闸限电之后，药企得注意这件事",
                "Correlation": 5,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "流感疫苗集中接种季",
            "original_text": "人民金融·创新药指数涨0.98% | 流感疫苗迎来集中接种季，三款重磅新药步入三期临床",
            "features": {
                "keywords": [
                    "创新药指数",
                    "流感疫苗",
                    "三期临床"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "人民金融·创新药指数涨0.98% | 流感疫苗迎来集中接种季，三款重磅新药步入三期临床",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "普瑞巴林缓释片获批",
            "original_text": "恒瑞医药(600276.SH)：普瑞巴林缓释片获得药品注册证书",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "普瑞巴林缓释片",
                    "药品注册证书"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "恒瑞医药(600276.SH)：普瑞巴林缓释片获得药品注册证书",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "吸入用七氟烷获批",
            "original_text": "恒瑞医药(600276.SH)：吸入用七氟烷获得药品注册证书",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "吸入用七氟烷",
                    "药品注册证书"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "恒瑞医药(600276.SH)：吸入用七氟烷获得药品注册证书",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "仿制药一致性评价通过",
            "original_text": "恒瑞医药：注射用环磷酰胺药品通过仿制药一致性评价",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "环磷酰胺",
                    "仿制药一致性评价"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "恒瑞医药：注射用环磷酰胺药品通过仿制药一致性评价",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "关节国采落地",
            "original_text": "医药健康行业周报(第三十七周)：关节国采落地 利空充分释放",
            "features": {
                "keywords": [
                    "关节国采",
                    "利空释放"
                ],
                "sentiment_score": -0.4,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药健康行业周报(第三十七周)：关节国采落地 利空充分释放",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "国内医药研发加速",
            "original_text": "国内医药研发“内循环”加速，重新定义Bigpharma的时刻到了",
            "features": {
                "keywords": [
                    "医药研发",
                    "内循环",
                    "Bigpharma"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "制药行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "国内医药研发“内循环”加速，重新定义Bigpharma的时刻到了",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "艾瑞妥新适应症获批",
            "original_text": "恒瑞医药艾瑞妥新适应症获批",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "艾瑞妥",
                    "新适应症"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "恒瑞医药艾瑞妥新适应症获批",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "两融余额减少",
            "original_text": "A股融资融券日报：两融余额减少32.66亿元（9月28日）",
            "features": {
                "keywords": [
                    "两融余额",
                    "减少"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "资本市场"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "A股融资融券日报：两融余额减少32.66亿元（9月28日）",
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "两项临床试验获批",
            "original_text": "恒瑞医药两项临床试验获批 分别用于治疗食管鳞癌、结直肠癌",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "临床试验",
                    "食管鳞癌",
                    "结直肠癌"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "恒瑞医药两项临床试验获批 分别用于治疗食管鳞癌、结直肠癌",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "A股成交额萎缩",
            "original_text": "A股成交额萎缩3000亿，原因在这？节前下跌节后上涨概率更大",
            "features": {
                "keywords": [
                    "A股",
                    "成交额",
                    "萎缩",
                    "节前下跌",
                    "节后上涨"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "资本市场"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "A股成交额萎缩3000亿，原因在这？节前下跌节后上涨概率更大",
                "Correlation": 2,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 1,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "资金流入民族品牌指数成分股",
            "original_text": "资金持续流入民族品牌指数成分股，机构看好投资价值",
            "features": {
                "keywords": [
                    "民族品牌指数",
                    "资金流入",
                    "投资价值"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "资本市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "资金持续流入民族品牌指数成分股，机构看好投资价值",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "药企加速创新升级",
            "original_text": "药企加速创新升级，持续研发能力受关注",
            "features": {
                "keywords": [
                    "药企",
                    "创新升级",
                    "研发能力"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "制药行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "药企加速创新升级，持续研发能力受关注",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]